Bal Pharma Ltd share price logo

Bal Pharma Ltd Share Price (BALPHARMA)

Check the latest share price of Bal Pharma Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹103.412.96%

as on 04:01PM, 13 Jun 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Bal Pharma Ltd Stock Performance

Get live Bal Pharma Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹101.05
    Day's Price Range
    ₹104.95
  • 52 Week's Low

    52 Week's High

    ₹78.06
    52-Week Price Range
    ₹157.98
1 Month Return+ 1.38 %
3 Month Return+ 27.1 %
1 Year Return-12.74 %
3 Year Return+ 7.55 %
5 Year Return+ 149.18 %
Previous Close₹106.56
Open₹104.90
Volume31.66K
Upper Circuit₹127.87
Lower Circuit₹85.24

Bal Pharma Ltd Fundamentals & Key Indicators

Check Bal Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹164.64 Cr

Return on Equity (ROE)

10.19

PE Ratio (TTM)

22.78

Return on capital employed (ROCE)

11.63

Industry PE ratio

57.39

Beta (LTM)

0.72

P/B Ratio

1.37

Dividend Yield

1.31

PEG Ratio

-55.55

Quarterly Earnings Growth YOY

-1.99

EPS (TTM)

4.71

Sector

Pharmaceuticals

Book Value

43.42

Technical Analysis

How to invest in Bal Pharma Ltd?

Investing in Bal Pharma Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Bal Pharma Ltd or BALPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Bal Pharma Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Bal Pharma Ltd with just a few clicks!

Bal Pharma Ltd Stock's Interest Amongst Investors

74%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Bal Pharma Ltd Stock has increased by 74% in the last 30 days, reflecting an upward trend in search activity.

Bal Pharma Ltd Valuation

Track how Bal Pharma Ltd P/E has moved over time to understand its valuation trends.

Bal Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-535.88x)

June 15, 2018

Today (22.78x)

June 13, 2025

Industry (57.39x)

June 13, 2025

Highest (203.65x)

September 12, 2018

LowHigh

Today’s Price to Earnings Ratio: 22.78x

Bal Pharma Ltd Financial Results

Get the annual and quarterly financial summary of Bal Pharma Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

95 (0%)74 (21%)74 (1%)73 (1%)82 (12%)
Net Income

(in ₹ Cr)

6 (0%)0 (95%)1 (300%)1 (50%)5 (942%)
Net Profit Margin5.84% (0%)0.35% (94%)1.41% (303%)0.71% (50%)6.62% (832%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

262 (0%)292 (12%)350 (20%)362 (3%)
Total Liabilities

(in ₹ Cr)

182 (0%)205 (13%)254 (24%)257 (1%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

22 (0%)10 (53%)31 (199%)5 (82%)29 (438%)

Bal Pharma Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Bal Pharma Ltd.

  • Bal Pharma Ltd Earnings Results

    Bal Pharma Ltd’s net profit fell -0.73% since last year same period to ₹5.43Cr in the Q4 2024-2025. On a quarterly growth basis, Bal Pharma Ltd has generated 1031.25% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Bal Pharma Ltd Dividends May,2024

    In the quarter ending March 2024, Bal Pharma Ltd has declared dividend of ₹1.20 - translating a dividend yield of 2.13%.

    Read More about Dividends

Bal Pharma Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Bal Pharma Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
50.86%
0.00
Foreign Institutions
0.14%
0.00
Mutual Funds
0%
0.00
Retail Investors
49%
0.00
Others
0%
0.00

Bal Pharma Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Bal Pharma Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA164.6429.84%0.797339
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Bal Pharma Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Bal Pharma Ltd.

  • Bal Pharma Reports Decline in Financial Performance - 10 Jun, 2025

    Bal Pharma's standalone net sales for March 2025 fell 13.53% year-on-year to Rs 81.78 crore. Quarterly net profit decreased by 9.84% to Rs 5.61 crore, while EBITDA dropped 29.72%. The EPS also declined to Rs 3.51. The stock has seen negative returns of -17.97% over the last 6 months and -15.97% over the last 12 months.

Insights on Bal Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, BALPHARMA stock has moved up by 2.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 0.48 Cr → 5.43 Cr (in ₹), with an average increase of 91.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 73.49 Cr → 82.96 Cr (in ₹), with an average increase of 5.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 58.0%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.14% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 50.86% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 49.00% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 123.5%

About Bal Pharma Ltd

BPL, a member of Macrolabs group, was incorporated in May 1987 and took over a pharmaceutical product manufacturing unit in Bangalore worth Rs 25.18 lac. The company manufactures and markets, pharmaceutical formulations such as paracetamol, aluminium hydroxide and povidone iodine. It came out with a public issue in Feb 1995 for the manufacturing of bulk drugs and expansion of pharmaceutical formulations. Additions to product range include AZIWIN CAFIMOL, CORTIDERM, Zanovid, Aziwin Dry Syrup, Meloxi Ocium, M Progit, MPS and Cardiac Specialities, AmilorideBenzydamine and Ebastine were added in 2002. BPL promotes its products through the sales force of the Macrolabs group and plans to launch its own soon. The unit has become a division of Bal Pharma Limited, thus marking an expansion in the drug production.

Revenue: ₹81.88Cr as on March 2025 (Q4 FY25)
Net Profit: ₹5.42Cr as on March 2025 (Q4 FY25)
Listing date: 08 May, 2006
OrganisationBal Pharma Ltd
HeadquartersBangalore
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Bal Pharma Ltd share price today?

Bal Pharma Ltd share price today stands at ₹103.41, Open: ₹104.9, Previous Close: ₹106.56, High: ₹104.95, Low: ₹101.05, 52 Week High: ₹157.98, 52 Week Low: ₹78.06.

What is today's traded volume of Bal Pharma Ltd?

Today's traded volume of Bal Pharma Ltd is 31.66K. Which means that 31.66K shares of Bal Pharma Ltd were bought and sold on the stock market during today's trading session.

What is Bal Pharma Ltd's market cap today?

Today's market capitalisation of Bal Pharma Ltd is ₹164.64 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Bal Pharma Ltd?

Bal Pharma Ltd’s 52 week high is ₹157.98 and 52 week low is ₹78.06. The current share price of Bal Pharma Ltd is ₹103.41, which is -34.54% down from its 52 week high and 32.48% up from its 52 week low.